In the news

First U.S. Trial of CRISPR- edited Immune Cells for Cancer Patients to Gauge Safety

Based on early data from the first-ever clinical trial in humans in the US, genetically editing a cancer patient’s immune cells using CRISPR/Cas9 technology and infusing them back into the patient seems to be safe and feasible. Three participants in the trial (two with multiple myeloma and one with sarcoma) …

Read More »

Lawsuits against Zantac

In ongoing lawsuits in the USA, claims have been made that Zantac and ranitidine contain unacceptable levels of the cancer-causing chemical N-Nitrosodimethylamine, or NDMA. Lawyers have charged that NDMA contamination causes stomach, liver, and bladder cancer. In September 2019, an online pharmacy had alerted the U.S. Food and Drug Administration …

Read More »

2020 Nobel Prize for Medicine

Once upon a time, getting a blood transfusion was a highly a risky affair, because some people receiving donated blood were apt to get chronic hepatitis (liver inflammation) from an unknown, mysterious disease. And, although the Hepatitis A and Hepatitis B viruses were discovered by the mid-1960s, in 1972, Prof. …

Read More »

The Vaccines are on the Way

  The development of the COVID-19 vaccine is a worldwide effort involving some of the best biological and pharmaceutical companies. Not only is it an effort involving massive amounts of money, but also, a race among nations for prestige and achievement. As of date, the leading companies with their COVID-19 …

Read More »

Global Study Finds Remdesivir ‘Unpromising’ for COVID-19

Results of a World Health Organization coordinated study show that remdesivir has “little or no effect on mortality” for patients hospitalized with coronavirus, and that it doesn’t seem to help patients recover any faster. Till date, this antiviral drug was the only drug that the US FDA had granted COVID-19 …

Read More »

After Sputnik V, EpiVacCorona

After government approval of Sputnik V, Russia’s first COVID-19 vaccine, on August 11, 2020, health authorities have, on October 14, 2020, approved its second vaccine, EpiVacCorona, developed by Novosibirsk’s Vektor [State Virology and Biotechnology Center], as it starts large-scale trials. According to President Putin, his deputy prime minister and the …

Read More »

Florida to release 750 million Genetically Modified Mosquitoes

In May 2020, the US Environmental Agency approved production of the genetically engineered, male Aedes aegypti mosquitoes, known as OX5034, by British-based, US-operated company Oxitec. This species of mosquitoes are known to spread deadly diseases like dengue, Zika, chikungunya, and yellow fever. On August 18, 2020, Florida Keys Mosquito Control …

Read More »

Regeneron Reigns Supreme

On June 11, 2020, Regeneron Pharmaceuticals initiated the first of its randomized, placebo-controlled clinical trials of REGN-COV2, its experimental dual antibody cocktail for the prevention and treatment of COVID-19. Th e trials were conducted at multiple sites and consisted of four study populations—hospitalized COVID-19 patients, non- hospitalized symptomatic COVID-19 patients, …

Read More »

Trumping COVID-19

Early on October 2, 2020, U.S. President Donald Trump, 74, revealed that he had tested positive for the novel corona virus. A day earlier, he had tested positive on a rapid test used for screening White House staff , which was later confirmed by a more accurate lab test. He …

Read More »

OPERATION WARP SPEEDD TO ACCELERATE VACCINE DEVELOPMENT

In the United States, Operation Warp Speed (OWS) is a collaboration of several US government departments, including Health and Human Services, and the private sector. Through it, the National Institutes of Health (NIH) has entered into collaboration with 18 bio pharmaceutical companies to accelerate development of drugs and vaccines to …

Read More »
Sahifa Theme License is not validated, Go to the theme options page to validate the license, You need a single license for each domain name.